Andrew Hykes, President and CEO at Inari Medical, Inc. (NARI), sold 3,000 shares at $55.23 ($166K) on 2024-07-22, disclosed to the SEC on 2024-07-24.
Scheduled sale ($166k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-03 | $150K | — | Filing → |